Loading clinical trials...
Loading clinical trials...
Evaluation of Dolutegravir Interactions With Artemether-Lumefantrine and Amodiaquine-Artesunate
Conditions
Interventions
Dolutegravir 50mg od
Artemether-lumefantrine combination
+1 more
Locations
1
Uganda
Infectious Diseases Institute
Kampala, Uganda
Start Date
June 1, 2015
Primary Completion Date
September 1, 2016
Completion Date
September 1, 2016
Last Updated
October 5, 2016
NCT01875588
NCT04929028
NCT07071623
NCT03087253
NCT07199335
NCT05419024
Lead Sponsor
University of Liverpool
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions